How weight-loss medications affect appetite and hunger hormones
Part of Hormones & metabolism clinical trials.
This study looks at how weight-loss medications affect appetite and the hormones that control hunger. It may help people who are starting or already taking these medications understand how they work and manage their weight better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 60 years old.
- Your body mass index (BMI) is between 30 and 45.
- You are either about to start or already taking a weight-loss medication like semaglutide or tirzepatide.
- You have not been diagnosed with type 1 or type 2 diabetes.
- You do not smoke.
- If you are a woman who could become pregnant, you must use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a special diet can help reduce stomach side effects (like nausea or vomiting) from weight-loss medications such as Wegovy or Mounjaro. It is for people who are about to start or are taking these medications.
This study looks at how anti-obesity medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) affect your muscles and movement. It may help researchers understand how to combine these drugs with exercise for better health.
This study looks at how diet, appetite, and body changes work together during weight loss. It's designed for people with a BMI of 30 to 50 who want to lose weight and are not taking certain medications or have certain health conditions.
This study tracks how your eating behavior changes when you take obesity medication. Researchers want to understand what happens to your appetite and food choices before, during, and after treatment to help improve how these medications work.
This study looks at how weight loss affects hunger in adults with obesity. It involves a walking program and may help you understand your appetite during weight loss.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
Hear when a new Obesity; Drug trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.